Document ID: chunk:federal_register_of_legislation:F2024C01281:clause:1ab_306
Version: federal_register_of_legislation:F2024C01281
Segment Type: clause
Provision Reference: sch 1AB cl 306
Character Range: 852754–855674

306       Quality use of Diagnostics, Therapeutics and Pathology Program                                                                                       To provide funding to improve the way in which health technologies, medicines and medical tests are prescribed and used, including:
                                                                                                                                                               (a) to develop and deliver educational materials on the appropriate use of medicines; and
                                                                                                                                                               (b) to provide appropriate healthcare interventions to promote the appropriate use of subsidised diagnostics, therapeutics and pathology; and
                                                                                                                                                               (c) to promote free access to information about the judicious and safe use of diagnostics, therapeutics and pathology; and
                                                                                                                                                               (d) to develop and provide tools and resources aimed at ensuring the appropriate, safe and efficacious use of medicines and health technologies; and
                                                                                                                                                               (e) to provide education and awareness activities, events, conferences and symposiums on the safe and appropriate use of medicines.
                                                                                                                                                               This objective has the effect it would have if it were limited to measures:
                                                                                                                                                               (a) for the provision of, or incidental to the provision of, pharmaceutical benefits, sickness benefits or medical services (within the meaning of paragraph 51(xxiiiA) of the Constitution); or
                                                                                                                                                               (b) to give effect to Australia's obligations under the International Covenant on Economic, Social and Cultural Rights, particularly Articles 2 and 12; or
                                                                                                                                                               (c) with respect to postal, telegraphic, telephonic, and other like services (within the meaning of paragraph 51(v) of the Constitution).